8329 related articles for article (PubMed ID: 2165192)
21. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
22. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
23. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia.
Johansson O; Liang Y; Emtestam L
Arch Dermatol Res; 2002 Feb; 293(12):614-9. PubMed ID: 11875644
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons.
Lee YJ; Zachrisson O; Tonge DA; McNaughton PA
Mol Cell Neurosci; 2002 Feb; 19(2):186-200. PubMed ID: 11860272
[TBL] [Abstract][Full Text] [Related]
25. Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells.
Kumar S; Huber J; Peña LA; Perez-Polo JR; Werrbach-Perez K; de Vellis J
J Neurosci Res; 1990 Nov; 27(3):408-17. PubMed ID: 1965839
[TBL] [Abstract][Full Text] [Related]
26. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate.
Mokuno K; Sobue G; Reddy UR; Wurzer J; Kreider B; Hotta H; Baron P; Ross AH; Pleasure D
J Neurosci Res; 1988; 21(2-4):465-72. PubMed ID: 2851058
[TBL] [Abstract][Full Text] [Related]
28. Clusterin expression in primary and metastatic melanoma.
Busam KJ; Kucukgol D; Eastlake-Wade S; Frosina D; Delgado R; Jungbluth AA
J Cutan Pathol; 2006 Sep; 33(9):619-23. PubMed ID: 16965336
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
[TBL] [Abstract][Full Text] [Related]
30. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
Dou YC; Hagströmer L; Emtestam L; Johansson O
Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
Wang YC; Tan Y
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):965-8. PubMed ID: 18756968
[TBL] [Abstract][Full Text] [Related]
32. Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro.
Rakowicz-Szulczyńska EM; Herlyn M; Koprowski H
Cancer Res; 1988 Dec; 48(24 Pt 1):7200-6. PubMed ID: 2461254
[TBL] [Abstract][Full Text] [Related]
33. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas.
Ohata C; Tadokoro T; Itami S
J Dermatol; 2008 Apr; 35(4):215-21. PubMed ID: 18419678
[TBL] [Abstract][Full Text] [Related]
34. Expression of nerve growth factor receptor in human peripheral neuropathies.
Sobue G; Yasuda T; Mitsuma T; Ross AH; Pleasure D
Ann Neurol; 1988 Jul; 24(1):64-72. PubMed ID: 2843078
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
37. [The role of Schwann cells in peripheral nerve degeneration and regeneration--NGF-NGF receptor system].
Sobue G
Rinsho Shinkeigaku; 1990 Dec; 30(12):1358-60. PubMed ID: 1966016
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor chromatin receptor and cell surface receptor-regulated growth of melanocytes and nevus cells.
Rakowicz-Szulczynska EM
J Biol Regul Homeost Agents; 1992; 6(1):1-7. PubMed ID: 1279947
[TBL] [Abstract][Full Text] [Related]
40. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
